Axim Biotechnologies, Inc. (AXIM): Depreciation & Amortization
Not updated since 2023-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.
$427.0K
Year ended 2023-12-31
+198.8%
3-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2023-12-31 | $427.0K | +0.2% | 2024-04-16, From 2023-01-01 |
| 2022-12-31 | $426.1K | -79.9% | 2024-04-16, From 2022-01-01 |
| 2021-12-31 | $2.12M | n/m | 2023-04-17, From 2021-01-01 |
| 2020-12-31 | $16.0K | n/a | 2022-04-19, From 2020-01-01 |
| No annual figure between 2016-12-31 and 2020-12-31. | |||
| 2016-12-31 | $3.4K | +199.9% | 2017-09-14, From 2016-01-01 |
| 2015-12-31 | $1.1K | n/a | 2017-09-14, From 2015-01-01 |
| 2014-12-31 | $0 | n/a | 2016-04-18, From 2014-01-01 |